- Home
- TERN vs ALHC Comparison
TERN vs ALHC Comparison
Compare TERN & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TERN | ALHC |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.8B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TERN | ALHC |
|---|---|---|
| Price | $37.25 | $20.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $48.60 | $21.05 |
| AVG Volume (30 Days) | ★ 3.5M | 2.8M |
| Earning Date | 11-10-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,637,156,000.00 |
| Revenue This Year | N/A | $48.62 |
| Revenue Next Year | N/A | $31.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.39 |
| 52 Week Low | $1.87 | $11.48 |
| 52 Week High | $48.26 | $21.65 |
Technical Indicators
Market Signals| Indicator | TERN | ALHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 64.30 |
| Support Level | $37.37 | $20.70 |
| Resistance Level | $40.84 | $21.65 |
| Average True Range (ATR) | 1.93 | 0.66 |
| MACD | -1.25 | 0.06 |
| Stochastic Oscillator | 2.11 | 78.36 |
Price Performance
Historical ComparisonAbout TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.